Clinical trials: Blood Clots
Deep Vein Thrombosis (DVT), Blood Clots
Below Knee DVT Study
Hospitalized patients are at risk of developing blood clots in the legs (Deep Vein Thrombosis or DVT), which can lead to death if those clots break off and migrate to the lungs.
- Trial name
- NCT03805672
- Testing
- Low Dose Enoxaparin, High Dose Enoxaparin
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Oregon Health and Science University
Stroke, Stroke, Acute
Volumetric Integral Phase-shift Spectroscopy for Noninvasive Detection of Hemispheric Bioimpedance Asymmetry in Acute Brain Pathology
The purpose of this study is to assess the ability of the Fluids Monitor to detect hemispheric bioimpedance asymmetry associated with acute brain pathology in patients presenting with suspected Acute Ischemic Stroke (AIS).
- Conditions
- Stroke, Stroke, Acute, Ischemic Stroke, Hemorrhage
- Trial name
- VITAL (NCT03148340)
- Testing
- VIPS Monitoring
- Where
- 5 sites in United States
- Volunteers
- 287 people
- Sponsor
- Cerebrotech Medical Systems, Inc.
Anticoagulants; Increased, Anticoagulant Overdosage
Noninvasive Measurement of Blood Coagulation
The investigators have developed an optical system that measures the coagulation status of patients in vivo in a non-invasive manner.
- Conditions
- Anticoagulants; Increased, Anticoagulant Overdosage, Coagulation Disorder, Blood Clot
- Trial name
- NCT03217799
- Testing
- Measurement of coagulability of blood
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Meir Medical Center
Crohn Disease, Blood Clot
Thrombin Generation in Crohn's Disease
One hundred and fifty patients with Crohn's disease involving the terminal ileum or the colon, in clinical remission, with or without endoscopic activity will be included.
- Conditions
- Crohn Disease, Blood Clot, Thrombosis
- Trial name
- NCT02445690
- Where
- 3 sites in Brazil
- Volunteers
- 150 people
- Sponsor
- University of Sao Paulo General Hospital
Blood Clot
A Prospective Pharmacodynamic Study of Rivaroxaban
The ability to explain bleeding or clotting complications in patients treated with rivaroxaban remains challenging. In addition, there is limited data on how coagulation tests perform in patients treated with therapeutic doses of…
- Trial name
- NCT01743898
- Testing
- Rivaroxaban, no anticoagulation
- Where
- United States
- Volunteers
- 65 people, healthy volunteers welcome
- Sponsor
- University of North Carolina, Chapel Hill